Filtros de búsqueda

Lista de obras de Tarah J. Ballinger

A Personalized, Dynamic Physical Activity Intervention Is Feasible and Improves Energetic Capacity, Energy Expenditure, and Quality of Life in Breast Cancer Survivors

artículo científico publicado en 2021

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

artículo científico publicado en 2020

Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling

artículo científico publicado en 2014

Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.

artículo científico publicado en 2014

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Discerning the clinical relevance of biomarkers in early stage breast cancer.

artículo científico publicado en 2017

Evaluating the Clinical Utility of Circulating Tumor Cells in Metastatic Breast Cancer-Is Not Worse Good Enough?

artículo científico publicado en 2020

How we manage JAK inhibition in allogeneic transplantation for myelofibrosis.

artículo científico publicado en 2014

Impact of body mass index (BMI) on presence of ctDNA and disease recurrence after neoadjuvant chemotherapy for triple negative breast cancer: analysis from BRE12-158

artículo científico publicado en 2020

Impact of primary breast cancer therapy on energetic capacity and body composition

article

Patient-reported outcomes in the Translational Breast Cancer Research Consortium

scientific article published on 19 November 2019

Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors.

artículo científico publicado en 2016

Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancer

artículo científico publicado en 2020

Subtyping of triple-negative breast cancer: implications for therapy

artículo científico publicado en 2014

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

artículo científico publicado en 2020

Triple Negative Breast Cancer—Review of Current and Emerging Therapeutic Strategies

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda